- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02619825
Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie)
Non-Invasive Evaluation of Myocardial Stiffness by Elastography Pediatric Cardiology Under
First, investigators must determine the physiological standards across age classes of myocardial stiffness estimated by Elastography in ultrafast (estimated right ventricular stiffness [VD] and left ventricular [LV]). This will be done in groups of children without heart condition, age group (10 children per group, four age groups [0-1mois, 1 month-1 year 1 year-5 years, 5 years-15years]).
Secondly, investigators will evaluate myocardial stiffness Elastography (RV and LV) on different groups of children (same age group) with cardiomyopathy and examine correlations with the conventional parameters of systolic and diastolic function of both ventricles and with myocardial strain values. The total population of the study will be 120 children (40 healthy, 80 patients).
Study Overview
Status
Intervention / Treatment
Detailed Description
Monocenter Prospective, open-label, non-randomized. All patients included in the study have a specific consultation built around a clinical examination and echocardiography, in two stages, with estimates of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and measures of all echocardiographic parameters estimated in children with a clinical ultrasound machine (Philips and General Electric).
Following this consultation, clinic and electrocardiographic monitoring period will be observed for 30 minutes, to ensure the safety of our procedure.
Required subjects: 40 healthy volunteers + 80 = 120 persons
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75005
- CHU Necker
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Group 1. Healthy Age criteria met by group [0-1mois, 1 month-1 year 1 year-5 years, 5 years-15years]
- consultation for heart murmur
- Recipient of a social protection scheme or entitled (excluding AME)
- Signed informed consent by the holders of parental authority
Group 2. Patients MHC nonobstructive:
- Age criteria met by group [1 month-1 year 1 year-5 years]
- Diagnostic criteria of non-obstructive HCM validated by the medical team of pediatric cardiology center (Necker)
- Recipient of a social protection scheme or entitled (excluding AME)
- Signed informed consent by the holders of parental authority
Group 3. Patients primitive CMD:
- Age criteria met by group [1 month-1 year 1 year-5 years]
- Diagnostic criteria of primary CMD validated by the medical team of pediatric cardiology center (Necker)
- Recipient of a social protection scheme or entitled (excluding AME)
- Signed informed consent
Exclusion Criteria:
Group 1. Healthy Patients:
- Age> 15 years
- Heart and Systemic Pathology identified
- metabolic and tissue pathology.
- known genetic pathology may have cardiac involvement.
- No echogenicity,
- Allergy echocardiography gel.
Group 2. Group CMH primitive Patients
- No echogenicity,,
- Allergy echocardiography gel.
- Arrhythmia.
- Pacemaker or defibrillator
Group 3. Patients primitive CMD:
- No echogenicity,,
- Allergy echocardiography gel.
- Arrhythmia.
- Pacemaker or defibrillator
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Group 1 "healthy volunteers
Echography and Elastography To determine physiological standards across age classes of myocardial stiffness estimated by Elastography in ultrafast (estimated right ventricular stiffness [VD] and left ventricular [LV]).
This will be done in groups of children without heart condition, age group (10 children per group, four age groups [0-1mois, 1 month-1 year 1 year-5 years, 5 years-15years]).
|
cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and measurement of all echocardiographic parameters estimated in children with a clinical ultrasound Machine
cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and
|
OTHER: Group 2 Patients CMH primitive
Echography and Elastography To evaluate myocardial stiffness Elastography (RV and LV) on different groups of children (same age group) with Hypertrophic Cardiomyopathy (HCM) non obstructive primitive and examine correlations with the conventional parameters of systolic and diastolic function of both ventricles and with myocardial strain values.
|
cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and measurement of all echocardiographic parameters estimated in children with a clinical ultrasound Machine
cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and
|
OTHER: Group 3 Patients primitive CMD:
Echography and Elastography To evaluate myocardial stiffness Elastography (RV and LV) on different groups of children (same age group) with Dilated Cardiomyopathy primitive and examine correlations with the conventional parameters of systolic and diastolic function of both ventricles and with myocardial strain values.
|
cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and measurement of all echocardiographic parameters estimated in children with a clinical ultrasound Machine
cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Myocardial diastolic stiffness UltrafastEcho (kPa)
Time Frame: through study completion, an average of 1 year
|
Normal values and intra-observer variability and inter-observer variability to demonstrate that the Aixplorer® myocardial elastography provides a reproducible assessment of myocardial stiffness.
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Olivier VILLEMAIN, MD, LAngevin Institute
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dilated Cardiomyopathy
-
Bristol-Myers SquibbTerminatedPrimary Familial Dilated CardiomyopathyUnited States, Germany, Spain, United Kingdom
-
Hospital General Universitario Gregorio MarañonMinisterio de Sanidad, Servicios Sociales e IgualdadUnknownPrimary Idiopathic Dilated CardiomyopathySpain
-
Nantes University HospitalCompleted
-
IRCCS SYNLAB SDNCompletedPatients With Ischemic or Idiopathic Dilated CardiomyopathyItaly
-
Capricor Inc.National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaboratorsUnknownHeart Failure | Ischemic Cardiomyopathy | Nonischemic Cardiomyopathy | Dilated Cardiomyopathy (DCM)United States
-
Ray HershbergerNational Heart, Lung, and Blood Institute (NHLBI); National Human Genome Research...Active, not recruiting
-
University of TehranCompletedDilated CardiomyopathyIran, Islamic Republic of
-
McGill University Health Centre/Research Institute...Unknown
-
Guangdong Provincial People's HospitalRecruiting
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline; AstraZenecaCompletedIdiopathic Dilated CardiomyopathyUnited States
Clinical Trials on Echography
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University Hospital, LimogesCompletedChondrocalcinosis | Articular Cartilage CalcificationFrance
-
AstesCompleted
-
University Hospital, GrenobleCompleted
-
University Medical Center GroningenCompletedEmphysemaNetherlands
-
University Hospital, Strasbourg, FranceTerminatedType 2 Diabetes | Silent Myocardial IschemiaFrance
-
Hospital NordCompletedRespiratory Failure | Failure; CardiacFrance
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting
-
Central Hospital, Nancy, FranceCompletedMyocardial InfarctionFrance
-
Javier LázaroSociedad Aragonesa de Patología del Aparato RespiratorioCompletedPneumonia, Viral | Covid19 | Respiratory FailureSpain